Krystal Biotech, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Krystal Biotech, Inc. has announced its 2026 Annual Meeting of Stockholders, scheduled for May 15, 2026, to address key corporate governance and compensation matters.
NASDAQ
Krystal Biotech, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Krystal Biotech's 2025 annual meeting will address director elections, auditor ratification, and executive compensation.
NASDAQ
Krystal Biotech, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Krystal Biotech will hold its 2024 annual meeting of stockholders virtually on May 17, 2024, to vote on director elections, auditor ratification, and executive compensation.